GC
USNA icon

Guggenheim Capital’s Usana Health Sciences USNA Stock Holding History

Guggenheim Capital’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,533
Closed -$477K – 1942
2024
Q2 		$477K Buy
+10,533
New +$485K ﹤0.01% 1452
2023
Q3 		– Sell
-8,556
Closed -$539K – 1919
2023
Q2 		$539K Sell
8,556
-2,385
-22% -$152K ﹤0.01% 1439
2023
Q1 		$688K Sell
10,941
-1,928
-15% -$115K 0.01% 1352
2022
Q4 		$685K Sell
12,869
-699
-5% -$37.9K 0.01% 1347
2022
Q3 		$761K Buy
13,568
+3,013
+29% +$199K 0.01% 1279
2022
Q2 		$764K Buy
10,555
+1,298
+14% +$96.7K 0.01% 1357
2022
Q1 		$736K Buy
9,257
+538
+6% +$48.5K ﹤0.01% 1514
2021
Q4 		$882K Sell
8,719
-5,976
-41% -$596K ﹤0.01% 1425
2021
Q3 		$1.35M Buy
+14,695
New +$1.41M 0.01% 1261
2021
Q2 		– Sell
-3,629
Closed -$354K – 2234
2021
Q1 		$354K Sell
3,629
-680
-16% -$61.9K ﹤0.01% 1886
2020
Q4 		$332K Buy
4,309
+355
+9% +$27.5K ﹤0.01% 1793
2020
Q3 		$291K Buy
+3,954
New +$317K ﹤0.01% 1648
2018
Q2 		– Sell
-26,214
Closed -$2.25M – 2608
2018
Q1 		$2.25M Sell
26,214
-9,183
-26% -$711K 0.01% 1545
2017
Q4 		$2.62M Buy
35,397
+362
+1% +$24.2K 0.01% 1463
2017
Q3 		$2.02M Buy
+35,035
New +$2.07M ﹤0.01% 1649
2016
Q1 		– Sell
-28,148
Closed -$1.8M – 2997
2015
Q4 		$1.8M Buy
28,148
+6,358
+29% +$412K 0.01% 1691
2015
Q3 		$1.46M Buy
21,790
+18,830
+636% +$1.33M ﹤0.01% 1840
2015
Q2 		$202K Buy
+2,960
New +$188K ﹤0.01% 2824
2015
Q1 		– Sell
-4,208
Closed -$216K – 3082
2014
Q4 		$216K Buy
+4,208
New +$207K ﹤0.01% 2777
2013
Q3 		– Sell
-37,554
Closed -$1.36M – 3184
2013
Q2 		$1.36M Buy
+37,554
New +$1.14M 0.01% 1792

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Guggenheim Capital's USNA Position: Q3 2024 in Review

Guggenheim Capital sold out of Usana Health Sciences (USNA) in Q3 2024, closing a stake of 10,533 shares — an estimated $477K sold.

Guggenheim Capital first reported a position in USNA in Q2 2013 and held it in 20 quarters. The position peaked at $2.62M in Q4 2017. 147 funds tracked by Wall St. Rank hold USNA as of Q3 2024.

  • Guggenheim Capital reported no remaining Usana Health Sciences position as of Q3 2024 after selling out during the quarter.
  • Guggenheim Capital sold 10,533 Usana Health Sciences shares in Q3 2024, an estimated $477K.
  • Guggenheim Capital first reported a position in Usana Health Sciences in Q2 2013 and held it in 20 quarters.
  • Guggenheim Capital's Usana Health Sciences position peaked at $2.62M in Q4 2017.
  • 147 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2024.

Based on Guggenheim Capital's 13F filing for Q3 2024, filed 13 Nov 2024.